Sign in

    Mitchell Moore

    Research Analyst at KeyBanc Capital Markets

    Mitchell Moore is an Analyst at KeyBanc Capital Markets, where he specializes in recommending investments within the technology and financial services sectors. He has demonstrated expertise in both primary and secondary markets, working with a range of publicly traded firms, though specific company coverage and quantifiable performance metrics are not publicly available. Moore began his finance career after earning his credentials and has been registered as a broker with FINRA since 2016, holding all requisite securities licenses. He continues to contribute to the industry with a focus on market research and investment analysis from KeyBanc's Cleveland headquarters.

    Mitchell Moore's questions to Hillenbrand (HI) leadership

    Mitchell Moore's questions to Hillenbrand (HI) leadership • Q3 2025

    Question

    Mitchell Moore questioned what prompted customers to move forward with large APS projects after the quarter's end and whether this signals a sequential backlog increase and future growth. He also asked if tariffs and recent activity are creating a more constructive pricing environment for the MTS segment.

    Answer

    CEO Kimberly Ryan attributed the order timing to customers finalizing how to navigate the trade environment, aided by Hillenbrand's 'in-region, for-region' manufacturing flexibility. While hopeful, she noted it's too early to call it a trend. For MTS pricing, she described the market as still competitive but confirmed that price-cost coverage has been improving dramatically over the last several quarters.

    Ask Fintool Equity Research AI

    Mitchell Moore's questions to Hillenbrand (HI) leadership • Q1 2025

    Question

    Mitchell Moore of KeyBanc Capital Markets asked about the rationale for selling a majority stake in the Milacron business rather than a full divestiture, the strategic fit of the remaining MTS assets, the pro forma margin profile of the remaining MTS business, and the updated timeline for reaching leverage targets.

    Answer

    CEO Kimberly Ryan stated the decision resulted from a regular portfolio review to maximize shareholder value, and the partnership structure with Bain Capital was deemed best for creating future returns and providing Milacron with growth resources. CFO Bob VanHimbergen added that the sale proceeds will reduce leverage by about 0.2 turns, bringing the year-end ratio to the 'low 3s,' still outside their target guardrails. He projected that in a normal environment, the remaining MTS business could achieve margins in the mid-to-high 20s.

    Ask Fintool Equity Research AI